Another study found that the expression of osteopontin resulted in poor response to treatment and survival of cancer cells.11,22 Since the medications used in the aforementioned two studies were different, it might be concluded that the type of drug resistance cannot be exclusive to one type of medication. Here, SPP1 is linked to cancer.